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Abstract
Background: WEB-Based Distress Management Program for Implantable CARdioverter defibrillator Patients (WEBCARE)
is a Web-based randomized controlled trial, designed to improve psychological well-being in patients with an implantable
cardioverter defibrillator (ICD). As in other Web-based trials, we encountered problems with attrition and adherence.
Objective: In the current study, we focus on the patient characteristics, reasons, and motivation of (1) completers, (2) those
who quit the intervention, and (3) those who quit the intervention and the study in the treatment arm of WEBCARE.
Methods: Consecutive first-time ICD patients from six Dutch referral hospitals were approached for participation. After signing
consent and filling in baseline measures, patients were randomized to either the WEBCARE group or the Usual Care group.
Results: The treatment arm of WEBCARE contained 146 patients. Of these 146, 34 (23.3%) completed the treatment, 88 (60.3%)
dropped out of treatment but completed follow-up, and 24 (16.4%) dropped out of treatment and study. Results show no systematic
differences in baseline demographic, clinical, or psychological characteristics between groups. A gradual increase in dropout was
observed with 83.5% (122/146) completing the first lesson, while only 23.3% (34/146) eventually completed the whole treatment.
Reasons most often given by patients for dropout were technical problems with the computer, time constraints, feeling fine, and
not needing additional support.
Conclusions: Current findings underline the importance of focusing on adherence and dropout, as this remains a significant
problem in behavioral Web-based trials. Examining possibilities to address barriers indicated by patients might enhance treatment
engagement and improve patient outcomes.
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Trial Registration: Clinicaltrials.gov: NCT00895700; http://www.clinicaltrials.gov/ct2/show/NCT00895700 (Archived by
WebCite at http://www.webcitation.org/6NCop6Htz).
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Introduction
The implantable cardioverter defibrillator (ICD) is a cardiac
device that is implanted with leads in and on the heart in patients
for the primary and secondary prevention of sudden cardiac
death due to life-threatening ventricular tachyarrhythmias [1,2].
In case of a ventricular arrhythmia, the ICD paces or delivers a
low- or high-voltage electric shock to the heart muscle to
terminate the arrhythmia and return the heart to a normal rhythm
[1,2]. The experience of the ICD shock is often described by
patients as “getting kicked in the chest by a big horse”, although
patients’ experiences vary considerably [3,4].
A subgroup of ICD patients experiences psychological distress
after ICD implantation, such as anxiety, depression,
post-traumatic stress, and impaired quality of life [5,6].
However, distress in patients may not necessarily be attributed
to the device and ICD therapy, but also to the underlying disease
[7,8] and patients’ pre-implantation psychological profile [9].
The importance of monitoring ICD patients for psychological
distress is increasingly being recognized [10], likely due to risk
for morbidity and mortality associated with patient distress
[11,12] and due to preliminary evidence suggesting that distress
is still undertreated in this population [13]. One possible
explanation for this is the lack of well-designed, validated,
randomized controlled trials (RCTs), leaving us with insufficient
knowledge for the establishment of a sufficient evidence base
to inform clinical practice [14]. Results of previous trials have
been promising with respect to reducing distress, but the
majority of these trials had a high dropout rate, jeopardizing the
external validity of these studies [15,16].
In order to make psychological treatment for ICD patients more
patient-tailored, which may reduce dropout, the use of online
Web-based interventions has been advocated [15,17]. There is
evidence showing that Web-based interventions are as effective
as face-to-face interventions [18,19], and might be able to
overcome barriers such as travel burden, time constraints, and
reluctance to seek help, and thus reach underserved groups of
patients [20,21]. However, adherence and attrition also remain
major challenges in these trials [22,23]. To date, the reasons for
dropout are not well understood and deserve attention in their
own right, in order to increase the success and applicability of
results of future Web-based intervention trials.
In the current study, we will describe the attrition and adherence
issues that we encountered during the “WEB-based distress
management program for implantable CARdioverter
dEfibrillator” patients (WEBCARE) trial (NCT00895700). The
trial design paper was published previously [24]. In brief, the
aim of WEBCARE was to reduce anxiety and depression and
improve the quality of life of patients with a first-time ICD
implant through a 12-week Web-based intervention (called
“Leef met je hart” or “Live with your heart”), using cognitive
behavioral therapy as the mainstay of treatment combined with
psycho-education related to the ICD and relaxation techniques.
Specific objectives were to (1) examine whether (a) completers,
(b) patients who dropped out of treatment but remained in the
study (filled in follow-up questionnaires), and (c) patients who
dropped out of the treatment and the study, differ systematically
on baseline demographic, clinical, and psychological
characteristics, and (2) present descriptive data on patients’
reasons for dropping out.
Methods
Patient Population
Consecutively implanted ICD patients from six hospitals in the
Netherlands (ie, Erasmus Medical Centre, Rotterdam; Amphia
Hospital, Breda; Catharina Hospital, Eindhoven; Onze Lieve
Vrouwe Gasthuis, Amsterdam; Canisius Wilhelmina Hospital,
Nijmegen; Vlietland Hospital, Schiedam) were approached for
study participation between April 2010 and February 2013.
Patients were eligible for participation if they fulfilled the
following inclusion criteria: first-time ICD implant, age 18-75
years, proficient in the Dutch language, and with Internet access
and a sufficient level of Internet skills. Exclusion criteria were
the following: life expectancy less than 1 year, history of
psychiatric illness other than affective/anxiety disorders, or on
the waiting list for heart transplantation.
Data Collection
Patients were approached by the ICD nurse or ICD technician
prior to or briefly after ICD implantation. They were informed
both verbally and in writing about the study. If the patient met
the inclusion criteria and was willing to participate, informed
consent was signed. Patients who could not decide at that time
were approached again after ICD implant while still hospitalized.
Prior to discharge from the hospital, consented patients were
provided with the first set of questionnaires (baseline) and their
medical records were accessed for information on their
demographic and clinical variables. After completing the
questionnaires, patients returned them in a self-addressed and
pre-stamped envelope to Tilburg University, Netherlands, which
served as the core lab for WEBCARE. If the questionnaires
were not returned within two weeks, patients received up to 3
reminder phone calls. Patients who did not want to participate
but who were willing to give access to information from their
medical records also signed an informed consent form. The
study was approved by the Medical Ethics Committee of all
participating centers and was conducted in accordance with the
Declaration of Helsinki. All patients provided written informed
consent.
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After receiving the baseline questionnaires and signed informed
consent, participants were randomly assigned to either of two
conditions: (1) the WEBCARE (WC) group, receiving
questionnaires at baseline, 3 months, 6 months, and 12 months
by mail, and getting access to the Web-based intervention for
a time period of 12 weeks to complete 6 modules online [24]
in addition to usual care, or (2) the Usual Care (UC) group,
receiving only questionnaires by mail at all time points and
usual care.
Patients were randomized using block randomization by
computer, randomizing 20 patients per hospital, at each time
point. Randomization lists were generated by an independent,
blinded statistician and sealed by a research assistant. For the
current analyses, we will only focus on patients who were
randomized to the WC group.
Descriptive Data
Patients who signed the informed consent form but who decided
to quit the intervention and/or the study prematurely were
contacted by telephone 12 weeks after randomization and asked
why they had decided to quit. This time interval was chosen in
order to not interfere with possible intervention effects (patients
were allowed to work at their own pace, some chose to finish
the intervention within the first two weeks, while others decided
to do the 6 lessons within the last two weeks. For that reason,
it was clear at 12 weeks who had quit or finished the
intervention). Hence, patients were contacted at the time that
they should have received their 3-month follow-up and finished
the 6-module online course.
Intervention: “Live with your Heart” (Leef met je
Hart)
The intervention was based on the previously developed
Web-based treatment “Alles Onder Controle” (Everything Under
Control) [25] and was for the purpose of the WEBCARE trial
adapted for ICD patients. The Alles Onder Controle treatment
was developed for the healthy depressed population and has
proven to be effective in reducing distress [25,26]. The
Web-based course for ICD patients is a 12-week intervention
of 6 online lessons addressing distress based on the cognitive
behavioral model (problem-solving treatment). The first lesson
focused on psycho-education with respect to living with an ICD
(eg, what are “normal” adaptation problems post ICD
implantation). In the second lesson, patients received homework
assignments and were provided with therapist feedback
(feedback was provided by master’s-level psychologists and
was intended as minimal guidance to help patients get through
the lessons—encouraging patients to continue with the lessons
and giving guidance on how to address their problems according
to problem-solving theory). In addition, patients received a
relaxation training CD, which they were allowed to use
throughout the intervention.
Patients were allowed to work at their own time and pace;
however, if a lesson was not finished within two weeks, a
reminder email was sent, with up to 3 reminders per lesson.
Patients could proceed to the next lesson only when the previous
one was finished and the homework assignment was sent to the
therapist. If patients did not log in within the first two weeks,
a reminder email was sent. Twelve weeks after receiving the
log-in information, patients’ accounts were automatically closed.
Measures
Demographic and Clinical Measures
Information on demographic variables (ie, age, gender, working
status, marital status, education level) was collected through
purpose-designed questions in the questionnaires, while
information on clinical variables (ie, left ventricular ejection
fraction [LVEF], QRS-width [electrocardiogram reading], New
York Heart Association functional class [NYHA-class], presence
of heart failure, use of cardiac and psychotropic medication)
were extracted from patients’ medical records at the time of
implantation by the implanting electrophysiologist or research
nurses at the participating centers. The Charlson Comorbidity
Index [27] was calculated based on self-report data and
information from patients’ medical records.
Anxiety
The Generalized Anxiety Disorder scale (GAD-7) was used to
assess anxiety [28]. The GAD-7 is a 7-item self-report
questionnaire assessing anxiety symptoms in the past two weeks
(eg, “Feeling nervous, anxious, or on the edge”). The GAD-7
is a reliable measure, with a Cronbach alpha of .92 and an
intraclass correlation of .83 [28]. The 7 items are rated on a
4-point Likert scale from 0 (not at all) to 3 (almost every day)
(score range 0-21), with a higher score indicating increased
anxiety symptoms.
Depression
The Patient Health Questionnaire (PHQ-9) is a 9-item self-report
measure of depression (eg, “Having little interest or pleasure
in doing things”) that taps into the 9 diagnostic criteria for
DSM-IV depressive disorder [29]. The PHQ-9 can establish
provisional depressive disorder diagnoses as well as grade
depressive symptom severity. Items are evaluated on a 4-point
Likert scale from 0 (not at all) to 3 (almost every day) (score
range 0-27), with a higher score indicating more depressive
symptoms [29]. The PHQ-9 has excellent reliability with a
Cronbach alpha of .91 and good validity, and has previously
been used in cardiac patients [30].
Type D (Distressed) Personality
Type D personality was assessed with the 14-item Type D scale
(DS14) [31], which consists of two 7-item subscales measuring
Negative Affectivity (eg, “I often feel unhappy”) and Social
Inhibition (eg, “I am a “closed” kind of person”) [32]. Items are
answered on a 5-point Likert scale ranging from 0 (false) to 4
(true), with total scores on both subscales ranging from 0 to 28.
A standardized cut-off ≥10 on both subscales defines individuals
with a Type D personality, as Item Response Theory has
indicated this to be the most optimal cut-off [31,32]. Both
subscales are internally consistent, with a Cronbach alpha of
.88 for Negative Affectivity and .86 for Social Inhibition. The
test-retest reliability for the two subscales over a 3-month period
were r=0.72 and 0.82, respectively [33].
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The Life Orientation Test (LOT) was used to assess optimism
and pessimism [34]. Optimism was measured using a sum score
of items 1, 4, 5, and 11; while pessimism was assessed with the
sum score of items 3, 8, 9, and 12. Items are answered on a
5-point Likert scale from 0 (very much disagree) to 4 (very
much agree). The total score for the optimism and pessimism
subscales ranges between 0 and 16, with a higher score
indicating higher levels of the respective trait [34].
Statistical Analyses
Continuous variables were compared using the Student’s t test,
while discrete variables were compared using the chi-square
test. Data are represented as percentages for nominal variables
and mean (SDs) for continuous variables. To compare groups
on psychological variables, ANOVAs (analysis of variance)
were performed. If group differences were observed, the
Tukey-Kramer post-hoc test for unequal group sizes was used
to identify which groups differed significantly. Descriptive data
were coded and analyzed using “frequencies”. A P<.05 indicated
statistical significance. All tests were two-tailed. Data were
analyzed using SPSS Statistics 19.0 for Windows.
Results
Patient Characteristics
A detailed description of the patient recruitment for WEBCARE
is displayed in Figure 1. A total of 1024 patients were
approached for participation, 735 (71.78%) were excluded due
to not meeting the inclusion criteria (n=492), refusing to
participate (n=192), or not returning baseline measures (n=51).
Eventually 289 patients were randomized to either the WC group
(n=146) or the UC group (n=143).
Demographic, clinical, and psychological characteristics of
patients who were randomized to the WC group are shown in
Table 1. The mean age of the group was 58.23 (SD 9.87) and
120 (82.2%, 120/146) were male patients. In addition, 106
(72.6%, 106/146) had a higher educational level.
Figure 1. Flowchart of patient recruitment.
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Table 1. Baseline demographic, clinical, and psychological characteristics of patients randomized to the WEBCARE treatment condition (WC; n=146).
WC group, mean (SD) or n (%)Characteristic
Demographics








20 (16.4%)NYHA class III/IVc, n=122
78 (53.4%)Heart failure






4.57 (5.02)Anxiety, mean (SD)
5.93 (5.11)Depression, mean (SD)
8 (5.5%)Psychological treatment
20 (13.8%)Cardiac rehabilitation, n=145
24 (16.4%)Type D personality
11.23 (2.68)Optimism, mean (SD)
5.73 (3.52)Pessimism, mean (SD)
aLVEF: left ventricular ejection fraction
bQRS-width: electrocardiogram Q,R, and S waves
cNYHA: New York Heart Association functional class
dCCI: Charlson Comorbidity Index
Non-Participants
Patients who did not return the baseline questionnaires (n=51)
and were excluded (not randomized) from current analyses did
not differ systematically on demographic variables. However,
significant differences on clinical variables were observed with
patients who were not randomized, more often having a NYHA
Class III/IV (P=.045), peripheral artery disease (P=.022), and
using psychotropic medication (P≤.001) (anxiolytics, P=.004
and hypnotics, P=.010). Of the patients who refused to
participate (n=192) but fulfilled the inclusion criteria, 60 (31.3%)
signed consent and gave permission for medical record screening
at the time of implantation. These patients were somewhat older
[60.26 (SD 1.80) vs 58.16 (SD 10.30); P=.04], more likely to
have a NYHA Class III/IV (34.1%, 14/41 vs 21.3%, 57/267;
P=.013), to have experienced a previous myocardial infarction
(76.6%, 36/47 vs 50.1%, 170/339; P=.001) or coronary artery
bypass grafting (34.0%,16/47 vs 19.2%, 65/339; P=.019), to
have peripheral artery disease (13.6%, 8/59 vs 5.3%, 18/339;
P=.018), or to have a cardiac resynchronization
therapy-defibrillator (CRT-D) (57.9%, 44/76 vs 25.9%, 87/336;
P<.001) as compared to patients who signed informed consent
for study participation (n=340).
Adherence and Attrition
Of the 146 randomized patients to the WC group, 34 (23.3%)
completed the treatment and filled in the follow-up assessment
(completers), 88 (60.0%) patients dropped out of the treatment
but remained in the study and filled in the follow-up assessments
(treatment dropouts), and 24 (16.4%) patients dropped out of
the treatment and the study (dropouts). Focusing on the
treatment, Figure 2 presents an overview of patients’ adherence
to the intervention and shows that the number of patients
completing the lessons diminishes over time. The first lesson
was completed by 83.5% (122/146) of the patients randomized
to the WC group (16.5%, 24/146 never logged in), while only
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23.3% (34/146) completed the last lesson (and thus the whole treatment schedule).
Figure 2. Adherence and attrition during the intervention (n=146).
Differences in Baseline Characteristics and
Psychological Profile
Completers and (treatment) dropouts did not systematically
differ on any baseline demographic, clinical, or psychological
measures (Table 2). Although not significant, dropouts tended
to be more often employed, have a lower education level, and
lower mean score on anxiety and depression as compared to the
other two groups. Table 2 shows a detailed overview of the
baseline demographic and clinical characteristics and
psychological profile of the three groups.
Table 2. Baseline demographic, clinical, and psychological characteristics stratified by group.
PDropout, n=24Treatment dropout, n=88Completers, n=34Characteristic
mean (SD) or n (%)
Demographic
.5656.42 (10.20)58.84 (9.84)57.91 (9.82)Age, mean (SD)
.5918 (75.0%)74 (84.1%)28 (82.4%)Gender (male)
.2315 (62.5%)38 (43.2%)15 (44.1%)Employed
.7121 (87.5%)73 (83.0%)30 (88.2%)Has partner
.4315 (62.5%)65 (74.7%)26 (76.5%)High education
Clinical
.9614 (58.3%)52 (59.1%)21 (61.8%)LVEF≤35a
.8310 (41.7%)37 (42.5%)12 (36.4%)QRS≥120b
.693 (15.0%)13 (20.0%)4 (13.3%)NYHA III/IVc
.8714 (58.3%)46 (52.3%)18 (52.9%)Heart failure
.161.38 (0.65)1.56 (1.10)1.88 (1.15)CCId, mean (SD)
.8120 (83.3%)69 (78.4%)28 (82.4%)Beta-blockers
.6612 (50.0%)52 (59.1%)18 (52.9%)ACE-inhibitors
.8613 (54.2%)43 (48.9%)16 (47.1%)Diuretics
.363 (12.5%)9 (10.2%)1 (2.9%)Psychotropics
Psychological
.474.63 (4.62)4.21 (5.08)5.46 (5.18)Anxiety, mean (SD)
.735.58 (5.17)5.79 (5.38)6.53 (4.40)Depression, mean (SD)
.703 (12.5%)14 (15.9%)7 (20.6%)Type D
.5510.75 (2.44)11.41 (2.74)11.12 (2.71)Optimism, mean (SD)
.715.79 (2.99)5.56 (3.40)6.15 (4.16)Pessimism, mean (SD)
aLVEF: left ventricular ejection fraction
bQRS-width: electrocardiogram Q,R, and S waves
cNYHA: New York Heart Association functional class
dCCI: Charlson Comorbidity Index
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Descriptive Data: Reasons for Dropout
The reasons given by patients for not completing the treatment
are displayed in Figure 3. Unfortunately, we were not able to
reach all patients to learn about their reasons for dropout. Of
the patients that we were able to reach, the majority (20.5%,
23/112) indicated that they faced technical problems (eg, the
computer was not working, the website was not responding,
problems with Internet connection): “My computer broke and
I don’t use it that often, so I would have to buy another one just
for the study; I didn’t wanted to do that” and “I got irritated
because the website was not responding when I tried to log in,
so I decided to quit”.
Time constraints were an issue in 15.2% (17/112) of patients
(“I started working, so I don’t have time to do the online
course”) and 10.7% (12/112) of patients were feeling fine and
did not need additional support: “I had trouble thinking of any
problems that I’m experiencing at this moment, as I don’t have
any. I’m feeling fine”; and “I don’t have any problems. I’m
happy that I have received the ICD. I feel reassured now”.
Additional reasons were that the treatment did not apply to the
patients’ needs (6.3%, 7/112): “I expected the course to be
addressing only ICD specific problems…more technical
problems. That’s why I decided to participate. I didn’t want to
discuss psychological issues as I don’t have any”, and having
already a lot to deal with (5.4%, 6/112): “I have just received
an ICD and I’m dealing with depressive symptoms; I have other
priorities at this moment”, and “I wanted to do the treatment
but not within the 12 weeks. I wanted to start at a later time
point because I had a lot to deal with immediately after the ICD
implantation”.
Other reasons for dropout included treatment as being too
confronting (4.5%, 5/112): “It was too personal, too confronting.
I realized that I had more problems than I thought”, and feeling
too sick (4.5%, 5/112): “It was too much. I had two surgeries
in the past half year and I’m now on the waiting list for heart
transplantation. I’m feeling sick all the time”. There were also
patients who experienced the treatment as too negative: “I was
feeling fine about my ICD, but when I started reading the content
of the online course, I started feeling unhappy and therefore I
decided to quit”, and “The homework assignments and
questionnaires are too negatively worded, while you expect us
to start thinking positive. I didn’t want to proceed as I didn’t
wanted to start thinking negative about the ICD and how I’m
feeling”.
Figure 3. Reasons for dropout (n=112).
Discussion
Principal Findings
This is the first behavioral randomized controlled trial to address
the adherence and dropout issues of a Web-based intervention
in the ICD population. Our findings show that 23.3% of patients
randomized to the treatment arm completed the full treatment
(six lessons), while 16.5% never logged on to the intervention.
A gradual decline in adherence was observed with more patients
dropping out as the lessons proceeded. The three groups
(completers, treatment dropout, and dropout) did not differ
systematically on any demographic or clinical baseline
characteristics and their psychological profile. The top 3 reasons
given for dropping out of the treatment were: technical issues
with the computer/website, time constraints, and feeling fine/not
needing additional support.
The findings of this study are generally in line with previous
findings from the “Alles Onder Controle” Web-based
intervention for individuals from the general population with
increased levels of anxiety or depression who volunteered to
undergo the intervention. Although generally higher percentages
of completers were reported (38-55%), the rate of patients who
never logged on was between 9% to 16% [25,26,35] and is in
accordance with the 16.5%, which was observed in the current
study. The higher number of completers in the Alles Onder
Controle study might be attributed to these individuals being
volunteers and thus highly motivated with respect to investing
time and effort in improving their well-being. In addition, the
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latter patients scored high on anxiety and depressive symptoms,
while patients in WEBCARE were included regardless of their
anxiety/depression levels, as WEBCARE was set up as a
prevention trial. However, there was a comparable gradual
decline in adherence in the previous studies as in patients in the
WEBCARE treatment arm [25,35].
In general, higher attrition rates are reported in open access
Web-based trials without therapist guidance [36], while the
number of completers is higher in closed trials where feedback
is provided and reminders are sent [23,37]. Looking more
specifically into cardiac patients (older adults with depression
and comorbid cardiovascular disease), in their qualitative study
on online treatment adherence, Donkin et al reported that time
constraints, competing priorities, perception of limited worth
of the intervention, and anxiety about spending time on the
computer were important factors that contributed to an increased
attrition [38], which are to some degree comparable to what we
found in the current study. Generally, their results showed that
adherence might increase if the benefits of participating in the
treatment outweigh the costs of participation. In the current trial,
the mean depression and anxiety scores were relatively low,
patients were not distressed, and likely did not see a need for
the treatment as they generally felt fine.
Studies of Web-based interventions have also shown that the
duration of treatment [39] and timing [40] of the treatment may
affect patients’ engagement. Also, patients’ perceived control
over completing the course and coaching via phone vs email
are found to be associated with higher completion rates [41].
In addition, printed delivery mode has shown to result in higher
attrition as compared to a Web-based delivery mode [42]. These
findings can partly explain why a higher attrition rate was
observed in the current study. Current results show diminished
participation after the third lesson. Perhaps, had the treatment
been somewhat shorter, more patients would have completed
all lessons. In addition, the treatment was offered immediately
after ICD implantation. As indicated by some patients, at that
time point they have a lot to deal with already and may for that
reason decide not to participate or complete all modules.
Limitations and Strengths
A number of limitations of this study must be acknowledged.
First, current analyses are based on a relatively small sample
and should be replicated in larger studies in the future. Second,
results on reasons for dropout are based on descriptive data that
were obtained via a telephone call to patients. A structured
interview or validated questionnaire would perhaps provide
more valid information. Third, unfortunately we were not able
to reach all patients at 12 weeks by telephone; hence, current
findings are based on patients who answered the phone and
were willing to provide us with information regarding their
reasons for dropout.
This study also has several strengths. To our knowledge, it is
the first behavioral intervention trial in ICD patients to have
used a Web-based approach and the first study in ICD patients
overall to address issues of adherence and attrition. The
information from WEBCARE adds to our knowledge about
factors that may influence adherence in trials using a Web-based
approach, which can be used when designing Web-based
behavioral intervention trials for ICD patients in the future, in
order to increase the number of patients enrolled in the study
and their treatment adherence.
When offering a Web-based intervention to ICD patients, it
seems of great importance to make the intervention as
patient-tailored as possible. Not all patients have the same needs
at the same time. Thus, giving them time and space to complete
the lessons when needed is an important factor as is making it
possible to select which lessons to complete (some patients are
more interested in technical aspects of the ICD, which would
give them more reassurance, while others prefer psychological
support in dealing with this new situation). As a proportion of
the ICD patients indicated that they were feeling fine and did
not need any additional support, it might be more important to
focus on patients who have higher distress levels post implant.
These patients could be identified using brief and standardized
questionnaires that are designed to assess psychological distress.
Close monitoring of patients’ psychological needs is warranted
as it has been associated with morbidity and mortality [11,12],
and may help us to provide the right amount of care that is
needed at the right time. Designing behavioral interventions
with a collaborative care approach, where a period of “watchful
waiting” is employed would perhaps be a way to go. With this
approach, we would be able to offer support to patients who
have “chronic” levels of distress or who develop distress at a
later time point, as we have now learned that the “one size fits
all” approach results in high dropout and low adherence.
Incorporating a standard intervention in current health care
models, which would be offered to all patients, might result in
a great loss of resources as only a small proportion of patients
would be willing to participate and complete the treatment (as
shown in current data).
Conclusions
In conclusion, as Web-based treatments are increasingly being
implemented in clinical practice, knowing how to keep patients
motivated and compliant with treatment becomes more
important every day. Our findings indicate that more attention
should be paid to the technical aspects of Web-based treatment
and making it more user-friendly. In addition, to overcome the
barrier of home computers not working as they should, future
studies should examine whether a similar intervention could be
delivered using smartphones or tablets in order to decrease
dropout. Also, future studies should examine the relationship
between adherence and outcomes, as the results to date are
inconclusive [22]. Examining the appropriate duration and
timing of the intervention is also of great importance, which to
date remains unexplored in the ICD population. The provision
of patient-tailored interventions at the time when the patient
needs it is likely to increase treatment adherence and enhance
the effectiveness of such interventions.
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